ストックスクリーナーアプリを入手
2.77
1.25%
-0.04
前日終値:
$2.81
開ける：
$2.84
24時間の取引高:
385.76K
Relative Volume:
0.24
時価総額：
$206.29M
収益：
$6.96M
当期純損益:
$-46.51M
株価収益率:
-16.14
EPS:
-0.1716
ネットキャッシュフロー:
$-37.99M
1週間 パフォーマンス:
+0.91%
1か月 パフォーマンス:
+15.62%
6か月 パフォーマンス:
-20.26%
1年 パフォーマンス:
-25.40%
1日の値動き範囲:
$2.765
$2.96
1週間の範囲:
$2.645
$2.96
52週間の値動き範囲:
$1.60
$5.3881
Perspective Therapeutics Inc Stock (CATX) Company Profile
名前
Perspective Therapeutics Inc
セクター
電話
509-375-1202
住所
350 Hills Street, Suite 106, Richland
CATX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
2.775 | 208.89M | 6.96M | -46.51M | -37.99M | -0.1716 |
|
ABT
Abbott Laboratories
|
126.91 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.45 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.76 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.58 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.63 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-24 | 再開されました | Truist | Buy |
| 2025-10-10 | 開始されました | BTIG Research | Buy |
| 2025-03-13 | 開始されました | H.C. Wainwright | Buy |
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2024-11-25 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-10-01 | 開始されました | Wedbush | Outperform |
| 2024-09-25 | 開始されました | Truist | Buy |
| 2024-07-25 | 開始されました | BofA Securities | Buy |
| 2024-05-09 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Perspective Therapeutics Inc (CATX) 最新ニュース
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Given Average Recommendation of “Buy” by Brokerages - Defense World
Why Perspective Therapeutics Inc. stock remains a top recommendationFederal Reserve Announcements & Investor Community Interactions - bollywoodhelpline.com
Perspective Therapeutics (NYSEAMERICAN:CATX) Trading Up 0.4%Should You Buy? - MarketBeat
Market Review: Will Perspective Therapeutics Inc stock continue upward momentumTrend Reversal & Risk Adjusted Buy and Sell Alerts - moha.gov.vn
Perspective Therapeutics (FRA:AAJ0) EV-to-OCF : -0.36 (As of Dec. 26, 2025) - GuruFocus
Aug Decliners: How Perspective Therapeutics Inc AAJ0 stock benefits from digital adoption2025 Stock Rankings & Daily Stock Trend Watchlist - moha.gov.vn
Perspective Therapeutics Inc Stock Analysis and ForecastRisk Management Strategies & Affordable Portfolio Tips - earlytimes.in
Can Perspective Therapeutics Inc. stock resist market sell offsWeekly Investment Recap & Weekly Momentum Picks - Улправда
Aug EndMonth: What market sentiment indicators show for Perspective Therapeutics Inc. (AAJ0) stockWeekly Profit Recap & Proven Capital Preservation Methods - Улправда
Perspective Therapeutics Earnings Notes - Trefis
Published on: 2025-12-20 10:25:50 - Улправда
How Perspective Therapeutics Inc. stock valuations compare to rivalsMarket Trend Review & Weekly Watchlist for Consistent Profits - Улправда
Published on: 2025-12-20 05:01:39 - Улправда
Market Review: What market sentiment indicators show for Perspective Therapeutics Inc. (AAJ0) stockQuarterly Growth Report & Low Risk High Win Rate Stock Picks - Улправда
Trading Recap: How Perspective Therapeutics Inc. stock valuations compare to rivals2025 Support & Resistance & AI Powered Market Trend Analysis - Улправда
Is Perspective Therapeutics Inc. stock in correction or buying zone2025 Fundamental Recap & Growth Focused Stock Reports - DonanımHaber
How Perspective Therapeutics Inc. (AAJ0) stock benefits from digital adoptionInsider Selling & Precise Trade Entry Recommendations - DonanımHaber
How Perspective Therapeutics Inc. stock compares to market leadersEarnings Growth Report & Community Supported Trade Ideas - DonanımHaber
Should I buy Perspective Therapeutics Inc. stock before earnings seasonJuly 2025 Spike Watch & Smart Investment Allocation Insights - Улправда
Will Perspective Therapeutics Inc. stock continue upward momentumGDP Growth & Safe Swing Trade Setups - Bölüm Sonu Canavarı
Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com
Perspective Therapeutics, Inc. (CATX) 6.37% in After-hours: Stock Rises Amid Increased Investor Engagement - Stocks Telegraph
EV Market: How strong is Perspective Therapeutics Inc stock earnings growthTrade Signal Summary & Precise Buy Zone Identification - moha.gov.vn
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Receives Average Rating of “Buy” from Brokerages - Defense World
Perspective Therapeutics Inc (CATX) Performance and Fundamentals Dashboard tells a completely different story - Setenews
What Is the Future of Remi Edelstahl Tubulars Limited Stock Expert Projections ExplainedCapital Gains Strategies & Maximize Gains Professionally - earlytimes.in
DHP India Limited Included in Top Momentum ScanRetail Trading Trends & Consistent Double Returns - earlytimes.in
What analysts say about Perspective Therapeutics Inc AAJ0 stockMorning Star Patterns & Download Your Free Wealth Map PDF - earlytimes.in
Affinity Asset Advisors LLC Decreases Holdings in Perspective Therapeutics, Inc. $CATX - Defense World
Perspective Therapeutics (NASDAQ: CATX) sees FMR disclose 0.4% stake - Stock Titan
Can Perspective Therapeutics Inc. stock sustain breakout momentumQuarterly Portfolio Report & High Accuracy Trade Signal Alerts - Newser
CATX SEC FilingsPerspective Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ASCO Gastrointestinal Cancers Symposium - marketscreener.com
Perspective Therapeutics (NYSE: CATX) to Present VMT-α-NET Data at 2026 ASCO-GI - Stock Titan
How Perspective Therapeutics Inc. stock moves on employment dataEarnings Recap Summary & Growth-Oriented Investment Plans - Newser
Can Perspective Therapeutics Inc. stock ride next bull market cycle2025 Analyst Calls & AI Enhanced Trade Execution Alerts - Newser
Perspective Therapeutics Announces Acceptance of VMT-α-NET - GlobeNewswire
Is Perspective Therapeutics Inc. stock attractive for growth fundsWeekly Trend Summary & Weekly Watchlist for Consistent Profits - Newser
How Perspective Therapeutics Inc. stock reacts to oil pricesGlobal Markets & Expert Curated Trade Setup Alerts - Newser
How Perspective Therapeutics Inc. stock compares with market leadersQuarterly Trade Summary & Long-Term Safe Return Strategies - Newser
Why Perspective Therapeutics Inc. (AAJ0) stock is listed among top recommendationsWeekly Trend Report & Technical Entry and Exit Tips - Newser
What downside risks could hit Perspective Therapeutics Inc. (AAJ0) stockBull Run & Verified Stock Trade Ideas - Newser
How Perspective Therapeutics Inc. stock reacts to stronger dollarWeekly Risk Summary & Capital Efficient Trading Techniques - Newser
Does Perspective Therapeutics Inc. (AAJ0) stock trade below intrinsic value2025 Valuation Update & Risk Controlled Stock Pick Alerts - Newser
Perspective Therapeutics Updates Corporate Presentation on Advancements - TipRanks
[8-K] Perspective Therapeutics, Inc. Reports Material Event | CATX SEC FilingForm 8-K - Stock Titan
Perspective Therapeutics (CATX) 10K Form and SEC Filings 2025 - MarketBeat
Perspective Therapeutics (CATX) Receives a Buy from RBC Capital - The Globe and Mail
Oppenheimer Sticks to Its Buy Rating for Perspective Therapeutics (CATX) - The Globe and Mail
Perspective Therapeutics Inc (CATX) 財務データ
収益
当期純利益
現金流量
EPS
0.62%
0.98%
大文字化:
|
ボリューム (24 時間):